The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
My apologies Bottom Feeder for puncturing your raw nerve...........................................
Your figures were inaccurate - FACT.
Please provide me with private contact details and I will gladly devote time to running through your previous email to correct your anomalies.
Like you I am long and strong of this share.
Seeing lots of small simultaneous price and times trades going through, think this is institutions using a bot (programmed computer) buying/selling
DarthInvestor: I'm already heavy on Fum in my portfolio. I'm almost £50k invested thus far, so hopefully that gives a clue how good I think the future is.
The share market is extremely difficult to call at present and for the next 6 months and I've decided that FUM provides one of the few 'guaranteed' double digit+ returns in the next 6 months.
So FUM is one of those shares I've invested heavily in on the basis that I'm happy to sit back and wait for a very good return.
I seldom ever listen to trolls who try to ramp shares and claim multibagger capabilities.
But.... FUM (imho) is now one of the few I actually think will double my investment within a year.
So, I'm happy to wait up to 12 months to make £50k+ profit.
And shall be topping up regularly.
Really hoping this will prove my loyalty as an actual long term investor.
P.S. as always "STRONG, STRONG BUY"
Gla
Yes, strong volume is a bullish indication, shows interest.
What we are really waiting for is USA distribution and sales. Then its woooooosh.
Volume up to 500k by 9am. Seems like something may be happening. Volume has really died down recently.
Interesting point Martinelwick but surely no RNS required ?
FUTURA is involved in the manufacturing of the gel NOT SALES OR DISTRIBUTION.
That is down to COOPER in Europe and the U.K.
COOPER is a privately owned company and as such is not subject to Stock Exchange disclosure rules .
Cooper certainly seem to be doing a brilliant job at the moment.
Roll on next Monday but it’s a shame that EROXON sales will only indicate two months of the six month interim period.
Good luck all long term FUMSTERS !
Arturo.
Clearly Boots had a time limited exclusive deal with FUM.That has expired and Eroxon is now available in many other outlets.This is very good news.My question is why was no RNS issued informing the market about this fundamental change.
One argument might be that clearly it hasn’t proved to be price sensitive given the ongoing stagnation of the share price.
My suspicion is that FUM want to trumpet this development next week.
However it should not be the case that but through the postings on this BB we would be completely ignorant of an important commercial development.
Too true bottom, this mid term report will only cover the weak launch for 2 months so will give indication as to royalties and maybe actual sales figures, units sold etc. This will be something to try and quantify their success, after that period more countries launched, mass tv adverts in UK and the saudi's will be selling for 3 months uo to year end, and the 4 mil upfront us payment so indeed their full year report will be banging. Id get in now if i wasnt already in, next year may not be around 50 zone prior to that yr end financials. :)
I think a lot of us are going to be very happy this time next week.
GLA.
Henners: By all means make stupid remarks on other peoples comments such as mine.
there is absolutely nothing wrong with my figures. They correlate with all the previous RNS figures.
If you think they are wrong then why don't you ACTUALLY wirte down the corrected figured rather than simply trying to 'imply' I, or anyone else is wrong.
You seem to think I am somehow 'rubbishingn' FUM. Yet my comment is FAR FROM IT. It is actually saying that the Full Year REport is going to be the Real Story of just how well the company has done.
I even propose that they will become net positive.
So get you own facts straight and stop trying to Troll others.
By all means if you don't like what I say...... then filter me.
P.S. You 'mightt' even notivve that I mark my opinion as £Strong Buy" on all my posts ...... IDIOT!
It's also for sale online at ChemistDirect for £19.99 with free postage over £35. No reviews on that site yet.
Seeing this pop up on shelves that get MASSIVE foot fall, I must admit I can see some explosive numbers coming. Not a pump but I used to work in FMCG and as soon as products like this hit big retail shelves the numbers shoot up. The SP has a very positive future imho. Just as an additional piece, getting listed in Tesco is NOT easy, that I can tell you from first hand experience. Anyway just some thoughts, great board, great product, sales momentum will be boiling
Thanks for checking this … let’s hope they keep on eye on displays etc
It was shown earlier today on Tesco website out of stock and £24.99.
But that disappeared. Probably launch tomorrow?
But can be ordered online at Superdrug now at £24.99.
Strap into your seats.
Yep, just been to our local Tesco. It's on the shelf in the pharmacy, but tucked away in a corner. A single line of boxes, no price on the shelf edge and no point of sale material, unlike the little blue pill which has lots of point of sale material on the front counter and several lines of boxes in a prominent position behind the counter. Wonder if that's because of a difference in margin/profit.
Also in select Superdrug stores and available to order online at Superdrug. (just checked)
If anyone’s able to do a in store check…. U never know with these google led things ….obviously bigger stores with pharmacies
Interesting news,thanks. it is encouraging to see the roll out continue..
Must be Tesco pharmacies
Bottom_feeder Please establish your "facts" carefully before putting fingers to keyboard. Your numbers are absolute tosh and therefore misleading to readers peeping into this chatroom.
The financials you claim were clearly informed to the market by RNS on 22nd June 2023 and 17th July 2023.
For the elimination of any doubt perhaps you would be kind enough to cut and paste your earlier message and correct your errant figures. Kind Regards.
The upcoming Interim Results up to June 2023 will liley 'disappoint' a few.
I project that there nay be some indication of a reduction in the 'net' Burn down, but the Final Results in June next year are where we are likely to see a move into Net Return.
However, the outlook for the Interims will definitely set the scene and I think the BOD will definitely want to paint the best possible Positive Guidance for the full results.
Most of the 'enthusiam' is based around the US marketability. We are unlikely to see any income from European sales for interim period. Sales are only in latter half.
The only viable income may be for the 'Undiclosed initial Payment' from Cooper et al. However, we don't know what that is. The US agreement has an initial £4m up front payment which won't show up aas they will likely be paid/captured in Latter half.
The Cash burn for 2022 was £6.34M. So, if they do get a £1M payment from Cooper then this may bring their interim cash burn to arround the £3M mark. i.e. I expect their cash burn to increase for the 2023 period as I suspect they will have greater outlays/payments relating to marketing activities.
I don't think we will see any sales figures as they would only be 'projected' figures.
The BIG footnote will be a statement or 2 added regarding the current and future sales figures //// since June 2023.
This isn't normally captured as they are future events. But it would be prudent for the Board to give shareholders/market some 'guidance' as to the expected/projected outcome for the full year.
In my view the Full Results will be extremely positive.
FM have the £4M initial payment from US Market.
They may include the Cooper initial payment in the full results as I suspect Cooper would not have paid it before June'23. So possible £1-2M.
Milestone payments are very 'sketchy' as the Cooper payments are 'undisclosed. while the US payments are £5M-£45M over 'several' years (just exactly what is meant by 'several' years). Worst case scenario it is the 5 Year deal period so milestone payments will be in £1M-£5M per annum.
Assuming £1-2M Milestone payments in the full year, this gives FM an income projection around £6M to £7M+.
So, This implies a 'potential' Net Profit declared in the Full results of around £0.5M-£1M+.
Anything above this is extremely positive.
IMHO
May be worth their while to sell up andd buy up 5times more before the expected rise